Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rxsight Inc (NQ: RXST ) 50.25 -0.13 (-0.26%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Rxsight Inc < Previous 1 2 3 Next > Peeling Back The Layers: Exploring RxSight Through Analyst Insights September 13, 2024 Via Benzinga RxSight Stock Sees Relative Strength Rating Rise To 91 August 19, 2024 On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. Via Investor's Business Daily Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings) August 06, 2024 Via Benzinga Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday August 06, 2024 Via Benzinga RxSight Analysts Slash Their Forecasts After Q2 Results August 06, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 06, 2024 We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! Via InvestorPlace RXST Stock Earnings: RxSight Beats Revenue for Q2 2024 August 05, 2024 RXST stock results show that RxSight beat on revenue for the second quarter of 2024. Via InvestorPlace RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) July 15, 2024 Via Benzinga Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket August 06, 2024 Via Benzinga The 3 Best Med Tech Stocks to Buy Now August 05, 2024 Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. Via InvestorPlace Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock? July 16, 2024 Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? Via Benzinga Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 10, 2024 Via Benzinga Why RxSight (RXST) Shares Are Falling May 09, 2024 RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock. Via Benzinga Do You Have Your Eye On Vision Care Stocks? May 20, 2024 For investors seeking stable and growing opportunities, eye care stocks are an attractive option. Via Talk Markets What 10 Analyst Ratings Have To Say About RxSight May 07, 2024 Via Benzinga RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 06, 2024 Via Benzinga Assessing RxSight: Insights From 8 Financial Analysts April 11, 2024 Via Benzinga Chart Of The Day: RxSight - Cashing In On Cataracts March 04, 2024 Earnings are estimated to increase 33.30% this year, increase an additional 26.60% next year and continue to compound at an annual rate of 19.00% for the next 5 years Via Talk Markets Forecasting The Future: 9 Analyst Projections For RxSight February 29, 2024 Via Benzinga Recap: RxSight Q4 Earnings February 28, 2024 Via Benzinga RxSight's Earnings Outlook February 27, 2024 Via Benzinga Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know February 12, 2024 Via Benzinga Earnings Scheduled For February 28, 2024 February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. Via Benzinga The Analyst Landscape: 8 Takes On RxSight January 29, 2024 Via Benzinga Breaking Down RxSight: 5 Analysts Share Their Views January 08, 2024 Via Benzinga Analyst Expectations for RxSight's Future December 13, 2023 Via Benzinga Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month January 25, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky." Via Benzinga 3 Stocks to Buy BEFORE They Become Household Names January 12, 2024 The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names. Via InvestorPlace Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.